A New Approach to Managing
by Tanya J. Uritsky, PharmD
Pain medications have gotten a lot of press over the past couple of years. It seems a new story about the dangers of pain medications is reported almost daily – from concerns about misuse, to overdose, to drug-drug interactions and overall safety. In light of recent news coverage, let’s review the basic principles of managing cancer-related pain as we sort through some of the new information that is out there.
Diagnosis: Lung Cancer
A diagnosis of lung cancer can leave you and your loved ones feeling uncertain, anxious, and overwhelmed. You have important treatment decisions to make, emotional concerns to manage, and insurance and financial paperwork to organize, among other practical concerns. Here are four keys to help you manage the disease and maximize your quality of life.
Polycythemia vera, or PV, is one of a group of progressive blood cancers called myeloproliferative neoplasms, or MPNs. This group also includes essential thrombocythemia and myelofibrosis. MPNs can affect anyone at any time, and there is no known cure.
Living Well with a Diagnosis of MPN
The journey through a diagnosis of a myeloproliferative neoplasm is different for each person, and there is no road map that will work for everyone. Different people need different things. Whether you are the person diagnosed with an MPN or a caregiver, we hope these ten tips that have been shared by others living with MPN will help you along the way.
Hope for the Future
by Leslie Ayensu Appiah, MD
Once you are cleared to attempt conception after cancer treatment, there is no additional risk of birth defects or miscarriages. Equally important, pregnancy does not adversely affect overall survival.
Your Guide to Bladder Cancer Treatment
Different types of treatment are available for people with bladder cancer. Some treatments are standard (the currently used treatment), and some are being tested in clinical trials. There are four types of standard treatment for bladder cancer.
Inspiration and Progress:
Our National Commitment to Defeat Cancer
by Douglas R. Lowy, MD, acting director of the National Cancer Institute
Every year, for the past two decades, the National Cancer Institute has had the honor of writing an article for Coping’s July/August issue. While searching for a fitting theme for this year’s contribution, I was struck by the challenge we sometimes face – both as individuals touched by cancer and as a nation – in articulating the inspiration needed to confront cancer.
What to Do If You’ve Been Diagnosed
with an MPN
Myeloproliferative neoplasms (MPNs) are a closely related group of progressive blood cancers in which the bone marrow typically overproduces one of the mature blood elements. Other shared features include tendencies toward blood clotting or bleeding, organ enlargement, bone marrow scarring (fibrosis), and a possibility of transformation. Although MPNs can strike anyone at any age, most people are affected in the sixth decade of life or later.